Venus Remedies announced in a press release that its Intellectual Property Rights (IPR) Department has filed its 7th Patent Application with the Indian Patent Office for a novel, safe, low dose, non-irritating, highly efficacious and physiologically compatible antibiotic for the treatment of bacterial / multi-bacterial infections in children.
The Patent titled “A Low Dose Combination Anti-biotic Formulation” is a novel treatment developed at Venus Medicine Research Centre. This formulation, a Fixed Dose Combination of a latest generation Carbapenem and a latest generation Amino-glycoside, will be the best available solution for treatment of multi-bacterial infections in Neo-Natals and children being 4-8 times more effective at the lowest possible dosage levels- Approx.83% reduction in dosage from conventional therapies-, minimal ototoxicity and nephrotoxicity among all available known similar treatments world wide till date.
No comments:
Post a Comment